Labware for 3D cell culture, low-bind labware, and glycan analysis kits are designed to accelerate life science ...

The global biopharmaceutical community is preparing to gather in Lisbon, Portugal, for the 20th edition of BIO-Europe Spring®, the premier springtime partnering conference for the industry, taking ...

In 1939, German scientists Otto Hahn (later a Nobel laureate in Chemistry) and Fritz Strassmann discovered the effect of ...

While previous research has shown that nervous tissue does emit biophotons via metabolic activity—and that entanglement ...

Scientists engineer E. coli to convert PET plastic bottle waste into L-DOPA, a primary treatment for Parkinson’s disease.

There’s no moon landing without Robert Goddard. This month marks 100 years since Goddard launched the first liquid fuel ...

A biotech company which aims to revolutionise drug testing using lab-grown human muscles has secured the backing of a seed-stage investor to accelerate its growth.

From mining to magnet manufacturing, the process for refining rare-earth elements is complex and intensive. The supply chain for such critical ...

In an environment in which information is abundant but understanding is scarce, some books stand out because they fundamentally change the way we think about society, technology, history, and human ...

DARE-PTB1 is a novel, investigational IVR designed to deliver bio-identical progesterone continuously for up to a 14-day period. It is being developed to reduce the risk of preterm birth in at-risk ...

Extends the budget period for the ~$2M total NIH grant funding award for DARE-PTB1 through November 2026• DARE-PTB1 targets preterm birth, for which there are no FDA-approved treatment options• Award ...

Scientists make Parkinson’s drug from used plastic bottles - Researchers said the breakthrough could lead to a ‘bio-upcycling industry’ that uses waste materials to make things like flavourings and ...